Znf92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin

HIGHLIGHTS

• who: Mohammad Kamran from the (UNIVERSITY) have published the research: ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin, in the Journal: (JOURNAL) of 20/Dec/2021
• what: The authors demonstrate that the downstream co-targets of HDAC1/7 include ZNF92, an unexplored transcription factor, with a single citation in the last three decades43. Lastly, the authors demonstrate that normal human breast luminal epithelium is composed of two subtypes of cells; those that are ZNF92 protein positive and others that are ZNF92 negative (Fig 6a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.